Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor for prevention of thrombotic events after prior myocardial infarction
jRCT2080221538Phase 3
- Sponsor
- AstraZeneca
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ticagrelor in myocardial infarction (MI) and coronary arteriosclerosis (3 arms), sponsored by AstraZeneca.
02
Drugs
ticagrelor
03
Conditions
myocardial infarction (MI)coronary arteriosclerosis
Beyond the preview
Go deeper on jRCT2080221538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221538.